Concepedia

Theodore J. Wigle

TJ

4

Publications

127

Citations

4

H-Index

2016

Active since

Affiliations

University of Toronto(Current)

Western University

London Health Sciences Centre

Theodore J. Wigle is an author at University of Toronto specializing in pharmacogenomics, drug resistance, and pathology.

Top concepts

MedicinePathologyToxicologyPharmacologyDrug ResistancePharmacogenomics

Publications per year

2016–2022

4

Publications

4

Alveolar-like Stem Cell–derived <i>Myb</i> <sup> <i>−</i> </sup> Macrophages Promote Recovery and Survival in Airway Disease

Michael L. Litvack, Theodore J. Wigle, Joyce Lee et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 46 citations

Impact of pretreatment dihydropyrimidine dehydrogenase genotype‐guided fluoropyrimidine dosing on chemotherapy associated adverse events

Theodore J. Wigle, Brandi L. Povitz, Samantha Medwid et al. · Clinical and Translational Science · 2021 · 44 citations · Full text

Fluoropyrimidine-associated toxicity and DPYD variants c.85T>C, c.496A>G, and c.1236G>A: impact of haplotype

Samantha Medwid, Theodore J. Wigle, Richard B. Kim · Cancer Chemotherapy and Pharmacology · 2022 · 20 citations

Medicine, Pathology, Fluoropyrimidine-associated Toxicity +6

Exercise-induced increases in the expression and activity of cardiac sarcoplasmic reticulum calcium ATPase 2 is attenuated in AMPKα<sub>2</sub> kinase-dead mice

Marc Morissette, Shanel E. Susser, Andrew N. Stammers et al. · Canadian Journal of Physiology and Pharmacology · 2019 · 17 citations

Rows per page

1–4 of 4